GT200800205A - Metodos par la prevención y tratamiento de condiciones que surgen de deficiencia de estrogeno local - Google Patents
Metodos par la prevención y tratamiento de condiciones que surgen de deficiencia de estrogeno localInfo
- Publication number
- GT200800205A GT200800205A GT200800205A GT200800205A GT200800205A GT 200800205 A GT200800205 A GT 200800205A GT 200800205 A GT200800205 A GT 200800205A GT 200800205 A GT200800205 A GT 200800205A GT 200800205 A GT200800205 A GT 200800205A
- Authority
- GT
- Guatemala
- Prior art keywords
- local
- vulvar
- vaginal
- methods
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A MÉTODOS PARA LA PREVENCIÓN Y TRATAMIENTO DE CONDICIONES QUE SURGEN DE DEFICIENCIA DE ESTRÓGENO LOCAL, TALES COMO DISPAREUNIA, ATROFIA VULVAR, ATROFIA VAGINAL, RESEQUEDAD VAGINAL, COMEZÓN VULVAR, COMEZÓN VAGINAL, ARDOR VULVAR, ARDOR VAGINAL, DISTROFIA VULVAR, VAGINITIS ATRÓFICA O DISFUNCIÓN SEXUAL MENOPÁUSICA; EN ALGUNAS MODALIDADES, LOS MÉTODOS INCLUYEN ADMINISTRACIÓN SISTÉMICA, POR EJEMPLO ORAL, DE UN ESTRÓGENO, TAL COMO ESTRÓGENO CONJUGADOS, Y UN PROGESTÁGENO, TAL COMO MPA, CONTEMPORÁNEAMENTE CON ADMINISTRACIÓN LOCAL DE UN ESTRÓGENO, POR EJEMPLO ESTRÓGENOS CONJUGADOS; EN ALGUNAS MODALIDADES, LOS MÉTODOS INCLUYEN LA ADMINISTRACIÓN ORAL DE ESTRÓGENOS CONJUGADOS Y MPA, Y LA ADMINISTRACIÓN VULVAR, VAGINAL O VULVAR Y VAGINAL, DE ESTRÓGENOS CONJUGADOS, POR EJEMPLO, EN UNA CREMA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78951706P | 2006-04-05 | 2006-04-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200800205A true GT200800205A (es) | 2009-05-15 |
Family
ID=38523460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200800205A GT200800205A (es) | 2006-04-05 | 2008-10-02 | Metodos par la prevención y tratamiento de condiciones que surgen de deficiencia de estrogeno local |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20070238713A1 (es) |
| EP (1) | EP2004200A2 (es) |
| JP (1) | JP2009532505A (es) |
| KR (1) | KR20080108120A (es) |
| CN (1) | CN101415427A (es) |
| AU (1) | AU2007234841A1 (es) |
| BR (1) | BRPI0709924A2 (es) |
| CA (1) | CA2644913A1 (es) |
| CR (1) | CR10259A (es) |
| EC (1) | ECSP088796A (es) |
| GT (1) | GT200800205A (es) |
| IL (1) | IL193810A0 (es) |
| MX (1) | MX2008012880A (es) |
| NO (1) | NO20083789L (es) |
| RU (1) | RU2008136024A (es) |
| WO (1) | WO2007118135A2 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100155594A1 (en) * | 2008-12-23 | 2010-06-24 | Goldman Mildred M | Mass spectrometry assay for estrogenic compounds |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| BR112014012444B1 (pt) | 2011-11-23 | 2021-12-14 | Therapeuticsmd, Inc | Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． | 天然の併用ホルモン補充療法剤及び療法 |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| EP3435977A4 (en) | 2016-04-01 | 2019-10-16 | Therapeuticsmd, Inc. | PHARMACEUTICAL COMPOSITION OF STEROID HORMONE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010034340A1 (en) * | 2000-03-20 | 2001-10-25 | American Home Products Corporation | Hormone replacement therapy |
| US20020173499A1 (en) * | 2001-03-16 | 2002-11-21 | Wyeth | Estrogen replacement therapy |
| US20030004145A1 (en) * | 2001-05-16 | 2003-01-02 | Leonard Thomas W. | Treatment of conditions relating to hormone deficiencies by administration of progestins |
-
2007
- 2007-04-05 EP EP07760168A patent/EP2004200A2/en not_active Withdrawn
- 2007-04-05 KR KR1020087024302A patent/KR20080108120A/ko not_active Application Discontinuation
- 2007-04-05 US US11/696,917 patent/US20070238713A1/en not_active Abandoned
- 2007-04-05 MX MX2008012880A patent/MX2008012880A/es unknown
- 2007-04-05 JP JP2009504473A patent/JP2009532505A/ja active Pending
- 2007-04-05 BR BRPI0709924-0A patent/BRPI0709924A2/pt not_active Application Discontinuation
- 2007-04-05 RU RU2008136024/14A patent/RU2008136024A/ru not_active Application Discontinuation
- 2007-04-05 CA CA002644913A patent/CA2644913A1/en not_active Abandoned
- 2007-04-05 AU AU2007234841A patent/AU2007234841A1/en not_active Abandoned
- 2007-04-05 WO PCT/US2007/066042 patent/WO2007118135A2/en active Application Filing
- 2007-04-05 CN CNA2007800124125A patent/CN101415427A/zh not_active Withdrawn
-
2008
- 2008-08-28 CR CR10259A patent/CR10259A/es not_active Application Discontinuation
- 2008-09-01 IL IL193810A patent/IL193810A0/en unknown
- 2008-09-03 NO NO20083789A patent/NO20083789L/no not_active Application Discontinuation
- 2008-10-02 GT GT200800205A patent/GT200800205A/es unknown
- 2008-10-06 EC EC2008008796A patent/ECSP088796A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL193810A0 (en) | 2009-08-03 |
| WO2007118135A2 (en) | 2007-10-18 |
| KR20080108120A (ko) | 2008-12-11 |
| ECSP088796A (es) | 2008-11-27 |
| MX2008012880A (es) | 2008-10-13 |
| AU2007234841A1 (en) | 2007-10-18 |
| WO2007118135A3 (en) | 2008-04-24 |
| JP2009532505A (ja) | 2009-09-10 |
| US20070238713A1 (en) | 2007-10-11 |
| CN101415427A (zh) | 2009-04-22 |
| NO20083789L (no) | 2008-09-30 |
| BRPI0709924A2 (pt) | 2011-07-26 |
| RU2008136024A (ru) | 2010-05-10 |
| EP2004200A2 (en) | 2008-12-24 |
| CA2644913A1 (en) | 2007-10-18 |
| CR10259A (es) | 2008-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200800205A (es) | Metodos par la prevención y tratamiento de condiciones que surgen de deficiencia de estrogeno local | |
| ECSP088390A (es) | Método para la anticoncepción hormonal preventiva bajo demanda | |
| IN2012DN02661A (es) | ||
| MX2012003551A (es) | Tabletas transformables via oral. | |
| CL2012000248A1 (es) | Compuesto conjugado de insulina; procedimiento de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; kit farmaceutico; uso en el tratamiento de trastornos mediados por insulina. | |
| AR060880A1 (es) | Uso de flibanserina para el tratamiento de trastornos posmenopausicos del deseo sexual | |
| CL2011000604A1 (es) | Compuestos derivados de multiheteroarilo, inhibidores de h-pgds, composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades inflamatorias y alergicas. | |
| GT201000144A (es) | " composiciones farmaceuticas " | |
| UY32925A (es) | Composiciones de corticosteroides de administración oral | |
| UA108741C2 (uk) | Фармацевтична композиція для екстреної контрацепції | |
| CL2011001712A1 (es) | Combinacion de 0,1 a 1 mg de al menos un estimulador de sgc seleccionado de un grupo definido con 2,5 a 20 mg de un inhibidor de pde5 seleccionado de otro grupo; formulacion farmaceutica que la comprende y uso en el tratamiento de la disfuncion sexual masculina. | |
| MXPA06013133A (es) | Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina. | |
| CO6531485A2 (es) | Composiciones farmacéuticas sólidas que contienen un inhibidor de la integrasa | |
| PH12015501783B1 (en) | Pharmaceutical compositions for the treatment of helicobacter pylori | |
| EA201171035A1 (ru) | Композиции, включающие модуляторы pde4, и способ их применения для лечения, профилактики и сопровождения туберкулеза | |
| EP2350131A4 (en) | Compositions and Methods for Inhibiting CRIPTO / GRP78 Complex Forming and Signaling | |
| PE20130147A1 (es) | Combinacion farmaceutica de teobromina y un agente antitusivo no opioide | |
| MX2010011193A (es) | Composicion farmaceutica liquida para el tratamiento y prevencion del dolor. | |
| PA8789101A1 (es) | Composición farmacéutica estable que comprende una sal de vinflunina hidrosoluble | |
| MX2018005345A (es) | Composiciones farmaceuticas de dimetil fumarato. | |
| ECSP13012765A (es) | Combinación y composición para el tratamiento de obesidad | |
| CO6751242A2 (es) | Combinación y composición para el tratamiento de obesidad | |
| UA108865C2 (uk) | Парентеральна фармацевтична композиція у вигляді суспензії уповільненого вивільнення, у низькій та наднизькій дозованій формі, у гормональній терапії при клімактеричному синдромі | |
| HN2012000527A (es) | Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico | |
| CU20080067A7 (es) | Método para la anticoncepción hormonal preventiva bajo demanda |